申请人:Hoechst Aktiengesellschaft
公开号:US05556854A1
公开(公告)日:1996-09-17
Pyridopyrimidinediones, processes for their preparation and their use as drugs A compound of the formula I: ##STR1## and/or physiologically acceptable salts of the compound of the formula I, and/or optionally stereoisomeric forms of the compound of the formula I, are suitable for the preparation of drugs for the treatment of circulatory disorders and/or neurodegenerative diseases.
吡啶吡嘧啶二酮类化合物,其制备方法及作为药物的用途。公式I的化合物:##STR1## 及/或公式I的化合物的生理上可接受的盐,和/或公式I的可选立体异构体形式,适用于制备用于治疗循环障碍和/或神经退行性疾病的药物。